Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Solid Biosciences (Nasdaq: SLDB) granted 8,150 restricted stock units to one newly hired employee as an employment inducement.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Solid Biosciences (Nasdaq: SLDB) granted 8,150 restricted stock units to one newly hired employee as an employment inducement.
The restricted stock units, or RSUs, vest in four equal installments on successive one-year anniversaries of the grant date, through the fourth anniversary. Each installment requires the employee’s continued service through its vesting date. The award was made under the 2024 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
Positive
- None.
Negative
- Minor point. Forward-looking: it has not happened yet and may not happen.8,150 restricted stock units create potential shareholder dilution as the employee award vests.
Key Figures
- Restricted stock units granted
- 8,150 RSUs
- One newly hired employee
- Vesting schedule
- 4 equal annual installments
- Through the fourth anniversary of the grant date
Historical Context
-
Prior grant of 6,580 RSUs to one hire under the same plan, vesting in four annual installments
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
restricted stock units financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHARLESTOWN, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced a grant of 8,150 restricted stock units (“RSUs”) to one newly hired employee.
The RSUs vest in four equal installments on each one-year anniversary of the grant date until the fourth anniversary of the grant date. Vesting of the equity awards is subject to the applicable employee’s continued service with the Company through each applicable vesting date.
This grant was made pursuant to the Company’s 2024 Inducement Stock Incentive Plan and was made as an inducement material to the employee’s acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
About Solid Biosciences
Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including SGT-003 for Duchenne muscular dystrophy (Duchenne), SGT-212 for Friedreich’s ataxia (FA), SGT-501 for catecholaminergic polymorphic ventricular tachycardia (CPVT), SGT-601 for TNNT2-mediated dilated cardiomyopathy and additional fatal, genetic cardiac diseases. The Company is also focused on developing innovative libraries of genetic regulators and other enabling technologies with promising potential to significantly impact gene therapy delivery cross-industry. Solid is advancing its diverse pipeline and delivery platform in the pursuit of uniting experts in science, technology, disease management, and care. Patient-focused and founded by those directly impacted by Duchenne, Solid’s mission is to improve the daily lives of patients living with devastating rare diseases. For more information, please visit www.solidbio.com and follow us on LinkedIn at Solid Biosciences and X at @Solid_Bio.
Solid Biosciences Investor Contact:
Nicole Anderson
Senior Director, Investor Relations and Corporate Communications
Solid Biosciences Inc.
investors@solidbio.com
Media Contact:
Amir Khan
Corporate Affairs Practice
Syneos Health
amir.khan@Syneoshealth.com
(347) 249-0230
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity inducement did Solid Biosciences (SLDB) grant to its new employee?
Solid Biosciences granted 8,150 restricted stock units to one newly hired employee. The award vests in four equal installments on annual grant-date anniversaries through the fourth anniversary, subject to continued service at each vesting date.